Publication | Open Access

Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials

Patient-reported OutcomesBreast OncologyPhase 3MedicineRandomised TrialsCancer ManagementClinical TrialsGynecologyOutcomes ResearchBreast CancerPharmacotherapyOncologyGynecology OncologyEndocrine-related CancerWomen's HealthOvarian Cancer